Hematologist at KCMH, Bangkok🇹🇭 Thrombosis and hemostasis. Past member of ISTH early career committee. Social media AE @jthjournal
Joined May 2017
- Tweets422
- Following534
- Followers348
- Likes856
Thita Joy Chiasakul retweeted
Had a great time at the Peer Mentoring: Early Career Professionals in the Spotlight session at #ISTH2025 🎤💡
Moderated by @joythitac
So cool to hear everyone’s journey from abstract to presentation—lots of insights, laughs, and inspiration 💬✨
@ChoHanChiang29
#HemeTwitter #EarlyCareer #MedicalLife #ISTH #Mentorship #AbstractTips @isth @IsthPresident
Thita Joy Chiasakul retweeted
📍New editorial from the @isth Early Career Committee highlighting the importance of interdisciplinary collaboration and its opportunities within the thrombosis and hemostasis field. 🔖
#ISTHEarlyCareer
@SarahSewar @kohli_shrey @beckyzon @Aaron_Iding @NicolaPotereMD
@Plateletpaul @gauer_s @joythitac @PoolePAR_ty @renee_eslick @zara_sayar
📣📣The ECC's latest editorial is out!
Hope you enjoy reading it as much as we enjoyed writing it
Interdisciplinarity within thrombosis and hemostasis: opportunities for early career professionals to find their niche -Journal of Thrombosis and Haemostasis jthjournal.org/article/S1538…
Thita Joy Chiasakul retweeted
Our recent research in collaboration with Roland Jäger and @cj_binder indicates that clonal haemopoiesis (CHIP) is a novel risk factor for (unprovoked) venous thromboembolism (VTE). Previously, CHIP has been identified as risk factor for atherosclerotic vascular disease.
Association of clonal haematopoiesis with recurrent venous thromboembolism: A case–control study @Cihan_Ay_MD
buff.ly/48HGAba
Thita Joy Chiasakul retweeted
Hi everyone! If you are looking for more places to follow JTH, you can find us where the sky is blue: jthjournal.bsky.social
*NOTE: We will still continue posting content here for now.
Thita Joy Chiasakul retweeted
Nice to see that the message getting through that the ONLY indication for IVC filter is contraindication to anticoagulation and acute venous thrombosis (DVT and/or PE) in the last 14 days. BUT message that prescriber must follow-up until IVC filter is out clearly still needs work
Inferior vena cava filter (IVCF) insertion declined from 2013 to 2021, yet retrieval rates remained low and nonretrieved IVCFs were associated with an increased risk of long-term complications, such as DVT and caval thrombosis. ja.ma/3YUAaSM
Thita Joy Chiasakul retweeted
The PDF of the guidance on the management of individuals with #hemophilia who have cleared the hepatitis C virus in now available in the @JTHjournal. You can not forget about the impact of hepatitis on the liver when you have cleared it. This figure and the text in the paper are the most relevant. tinyurl.com/yz7s875m
Thita Joy Chiasakul retweeted
The Thai Red Cross Society is inviting healthy blood donors to celebrate Halloween this year by donating blood in Halloween costume this Friday.
Read more: world.thaipbs.or.th/detail/t…
#ThaiPBSWorld #ThailandNews #blooddonation #RedCross #Halloween
Thita Joy Chiasakul retweeted
How do you go about planning #ClassicalHematology sessions to attend at #ASH24? Would love for attendings/fellows to share how they approach it. I’ll keep adding replies to this tweet based on what I learn and plan to attend!
@ASH_hematology @HTRStoday @HTRSFellows
Thita Joy Chiasakul retweeted
Scientist by day, Musician by night.
Highly recommended listening to this #podcast hosted by @GBarnesMD with @DanielSteinerMD on his research in #VTE & experiences. Great example of the valuable contribution of young researcher to #thrombosis. #WTDay24
jthjournal.org/article/S1538…
🎙️New podcast episode just dropped! Our latest episode features @GBarnesMD & Daniel Steiner, an early career researcher, sharing his insights into the psychological consequences of VTE, as highlighted in his @JTHjournal paper!
Tune in: pod.link/1555328920
Thita Joy Chiasakul retweeted
We are ready for the Thrombosis Day tomorrow at Ramathibodi Hospital. Please join the interesting activity from 0830 to 1100 AM.
#WTday24 @IPTNetwork @thrombosisday
Thita Joy Chiasakul retweeted
Join us in welcoming several 2024 Associate Editors! Thank you for joining us in our mission to advance science related to the important medical problems of thrombosis, bleeding disorders and vascular biology through the diffusion and exchange of information and ideas within the international research community. Click here for more info bit.ly/3BLlkVm
Thita Joy Chiasakul retweeted
📣 Calling all early career ISTH members: Curious about career options beyond academia? 🧑🔬👩🔬 Join our next webinar on October 22 to explore exciting research career paths available to you!
🔗 Register here: us02web.zoom.us/webinar/regi… #ISTH #ResearchCareers
Thita Joy Chiasakul retweeted
To use or not to use reversal agents for DOACs? 🤔
Not all DOAC-associated bleeds require reversal.
This table summarizes guidance from @isth SSC on this issue
✍️@JerroldLevy @LanaCastellucci @connors_md @DebSiegal
Read this important paper at jthjournal.org/article/S1538…
Thita Joy Chiasakul retweeted
Terrific 2 days of meetings to plan sessions for the 2025 @isth Congress. Name your favorite #hemostasis or #thrombosis topic. It will be there. So should you! #science 🩸
Thita Joy Chiasakul retweeted
🧵Thread on the ANNEXA trials for reversing DOAC-related bleeds 🩸
As #DOAC (FXa inhibitors) have increasingly replaced VKAs, let’s discuss the development and study of their reversal agent #andexanet alfa, a recombinant inactive FXa that sequesters FXa inhibitor molecules
1/
Thita Joy Chiasakul retweeted
Delighted to have our paper accepted for publication @RPTHjournal!
Thank you to all co-authors for their help, in particular @racampbell04 and @abigail_ajanel for supporting me during my @isth training fellowship last year!
This Post is from an account that no longer exists. Learn more
Thita Joy Chiasakul retweeted
Great review on perioperative managent of DOAC treated patients by Dr Douketis and @AlexSpyropoul from JAMA
Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. ja.ma/4fIm1hL
Thita Joy Chiasakul retweeted
In preparation for #ISTH2025, Congress Chair @GuyYoungMD and the members of the Annual Congress Planning Committee are posting regular updates on the planning process via the Congress Chronicle.
Check it out: isth2025.org/congresschronic…
Thita Joy Chiasakul retweeted
Hi ISTH X community. Please share this for me: We've lost access to our ISTH X/Twitter account, and we're working to recover it. If you receive any contact or DMs from ISTH, please do not engage. I have not received any reports of this happening yet, but I wanted to alert you.
Thita Joy Chiasakul retweeted
Thank you to everyone who attended #ISTH2024. I am honored and excited to step into the role of President of @isth and look forward to working with all of you. A heartfelt thank you to @flora_peyvandi for her dedication and leadership as the Immediate Past President!
